Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M Folegatti; Katie J Ewer; Yasmine Yau

doi:10.1016/s0140-6736(20)31604-4

doi.org/10.1016/s0140-6736(20)31604-4

Clinical trial paper

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M Folegatti,Katie J Ewer,Yasmine Yau

The Lancet88.50

Volume: 396, Issue: 10249, Pages: 467 - 478

Published: Jul 20, 2020

Paper Fields

Paper Details

Title

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

DOI

doi.org/10.1016/s0140-6736(20)31604-4

Published Date

Jul 20, 2020

Journal

The Lancet

Volume

396

Issue

10249

Pages

467 - 478

Notes

History